A key pharmacological challenge in the drug's design is balancing glucagon receptor activity to avoid unwanted increases in hepatic glucose production and net hyperglycaemia, which would counteract the glucose-lowering effects of GLP-1 and GIP agonism
This creates both incredible opportunities and unexpected challenges that require intentional navigation to prevent rebound effects and build habits that last beyond the medication
Patients without insurance may consider assistance programs offered by the medication manufacturer, look for discounts through pharmacy savings plans, or explore patient assistance programs that sometimes cover all or part of the cost of medications
2015;10(8):e0134172. Wang H, Zhu C, Ying Y, Luo L, Huang D, Luo Z
Thanks, Saba, for such a great product
So we havent launched